Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist [Phase 2]
Phase 2 trial update for a tumor and vaccine site using a Toll-Like Receptor agonist in melanoma; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-11Clinical Trial Update: Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies [Phase 1, Phase 2]
Phase Ib/II study evaluating MCS110 with PDR001 in advanced malignancies; completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: RADVAX™: A STRATIFIED PHASE I/II DOSE ESCALATION TRIAL OF HYPOFRACTIONATED RADIOTHERAPY FOLLOWED BY IPILIMUMAB IN METASTATIC MELANOMA [Phase 1, Phase 2]
A stratified Phase I/II trial (RADVAX) assessing hypofractionated radiotherapy followed by ipilimumab in metastatic melanoma has completed e…
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: A Pilot Study of Sequential ONCOS-102, an Engineered Oncolytic Adenovirus Expressing GMCSF, and Pembrolizumab in Patients With Advanced or Unresectable Melanoma Progressing After Programmed Cell Death Protein 1 (PD1) Blockade [Phase 1]
Phase 1 trial evaluating sequential ONCOS-102 plus pembrolizumab in advanced or unresectable melanoma progressing after PD-1 blockade.
-
CLINICAL_TRIALS trial_result · 2021-08-04Clinical Trial Update: Study of Gene Modified Immune Cells in Patients With Advanced Melanoma [Phase 2]
Phase 2 clinical trial update for gene-modified immune cells in patients with metastatic melanoma; study completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma [Phase 1, Phase 2]
Phase 1/2 trial investigating intratumoral SD-101 with pembrolizumab in metastatic melanoma or recurrent/metastatic head and neck squamous c…
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: Camrelizumab Plus Amlotinib and Chemotherapy in the First-line Treatment of Melanoma [Phase 2]
A Phase 2 clinical trial update evaluating camrelizumab plus amlotinib and chemotherapy as first-line treatment for melanoma.
-
CLINICAL_TRIALS trial_result · 2021-07-22Clinical Trial Update: An Investigational Immuno-therapy Study of Nivolumab Combined With Ipilimumab Compared to Nivolumab by Itself After Complete Surgical Removal of Stage IIIb/c/d or Stage IV Melanoma [Phase 3]
A Phase 3 trial evaluating nivolumab alone versus nivolumab plus ipilimumab after complete surgical removal of advanced melanoma; results ha…
-
CLINICAL_TRIALS trial_result · 2021-07-12Clinical Trial Update: Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma [Phase 3]
This Phase 3 trial compares the combination of encorafenib (LGX818) plus binimetinib (MEK162) against vemurafenib monotherapy and encorafeni…
-
CLINICAL_TRIALS trial_result · 2021-07-09Clinical Trial Update: An Investigational Immuno-therapy Study of BMS-986205 Combined With Nivolumab, Compared to Nivolumab by Itself, in Patients With Advanced Melanoma [Phase 3]
Phase 3 trial comparing BMS-986205 combined with nivolumab vs nivolumab alone in advanced melanoma completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-07-01Clinical Trial Update: GEM STUDY: Radiation And Yervoy in Patients With Melanoma and Brain Metastases [Phase 2]
Phase 2 trial evaluating the combination of Radiation and Yervoy (ipilimumab) in melanoma patients with brain metastases has completed with …
-
CLINICAL_TRIALS trial_result · 2021-06-24Clinical Trial Update: RTA 408 Capsules in Patients With Melanoma - REVEAL [Phase 1, Phase 2]
Phase 1/Phase 2 trial update on RTA 408 capsules in melanoma patients, including unresectable stage III and metastatic stage IV disease. The…
-
CLINICAL_TRIALS trial_result · 2021-06-21Clinical Trial Update: Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma [Phase 3]
Phase 3 trial comparing hepatic arterial infusion with melphalan to standard therapy in unresectable liver metastases due to melanoma comple…
-
CLINICAL_TRIALS trial_result · 2021-06-16Clinical Trial Update: Evaluation of Cytokine Biomarkers in Melanoma Patients During Immunotherapy [Phase 2]
Phase 2 trial evaluating cytokine biomarkers in melanoma patients undergoing immunotherapy.
-
CLINICAL_TRIALS trial_result · 2021-06-15Clinical Trial Update: Efficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV Melanoma [Phase 3]
A Phase 3 trial comparing nivolumab to ipilimumab as adjuvant therapy to prevent recurrence after complete resection of stage IIIb/c or stag…
-
CLINICAL_TRIALS trial_result · 2021-06-15Clinical Trial Update: Nivolumab Combined With Ipilimumab Followed by Nivolumab Monotherapy as First-Line Treatment for Patients With Advanced Melanoma [Phase 3]
Phase 3 trial evaluating nivolumab with ipilimumab followed by nivolumab monotherapy as first-line treatment for advanced melanoma has compl…
-
CLINICAL_TRIALS trial_result · 2021-06-08Clinical Trial Update: Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma [Phase 4]
Phase 4 clinical trial update for Aldesleukin in participants with metastatic renal cell carcinoma or metastatic melanoma has completed with…
-
CLINICAL_TRIALS trial_result · 2021-06-08Clinical Trial Update: A Study of E7050 in Combination With E7080 in Participants With Advanced Solid Tumors (Dose Escalation) and in Participants With Recurrent Glioblastoma or Unresectable Stage III or Stage IV Melanoma After Prior Systemic Therapy (Expansion Cohort and Phase 2) [Phase 1, Phase 2]
A phase 1/2 study of E7050 in combination with E7080 in advanced solid tumors and specific recurrent/unresectable cancers; the trial status …
-
CLINICAL_TRIALS trial_result · 2021-05-28Clinical Trial Update: A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued. [Phase 2]
A Phase 2 rollover study of tremelimumab for patients who had received it in other protocols, to provide continued access until it becomes c…
-
CLINICAL_TRIALS trial_result · 2021-05-27Clinical Trial Update: Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery [Phase 3]
This is a Phase 3 clinical trial update comparing ipilimumab to high-dose interferon alfa-2b in patients with resected high-risk Stage III–I…
-
CLINICAL_TRIALS trial_result · 2021-04-29Clinical Trial Update: Safety Study of a Helper Peptide Vaccine Plus Adjuvant Combinations for the Treatment of Melanoma [Phase 1, Phase 2]
A safety study of a helper peptide vaccine plus adjuvant combinations for melanoma was conducted in Phase 1/2 and terminated with results po…
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Dabrafenib/Trametinib/Hydroxychloroquine for Advanced Pretreated BRAF V600 Mutant Melanoma [Phase 1, Phase 2]
Clinical trial update evaluating dabrafenib, trametinib, and hydroxychloroquine in advanced pretreatment BRAF V600 mutant melanoma (Phase 1/…
-
CLINICAL_TRIALS trial_result · 2021-04-20Clinical Trial Update: Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating a vaccine therapy with or without cyclophosphamide in patients who had surgery for stage II–IV melanom…
-
CLINICAL_TRIALS trial_result · 2021-04-15Clinical Trial Update: Uptake and Biodistribution of 89Zirconium-labeled Ipilimumab in Ipilimumab Treated Patients With Metastatic Melanoma [Phase 2]
Phase 2 clinical trial update evaluating uptake and biodistribution of 89Zirconium-labeled ipilimumab in patients with metastatic melanoma w…
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Study of NY-ESO-1 ISCOMATRIX® in Patients With High-risk, Resected Melanoma [Phase 2]
Phase 2 trial evaluating NY-ESO-1 ISCOMATRIX in high-risk, resected melanoma has completed with posted results.